3 April 2023
\n \n \n \nProfessor Dame Sarah Gilbert from the Pandemic Sciences Institute was awarded the prestigious 2023 King Faisal Prize in recognition of her work to co-create a COVID-19 vaccine that has saved an estimated six million lives.
\n \n\n \n \n30 March 2023
\n \n \n \nFour UK centres will conduct the \u2018Stratification of Clinically Vulnerable People for COVID-19 Risk using Antibody Testing (STRAVINSKY)\u2019 study over the next two years, to identify the patient groups most vulnerable to COVID-19.
\n \n\n \n \n27 March 2023
\n \n \n \nThe Pandemic Sciences Institute and the UK's Defence Science and Technology Laboratory (Dstl) have agreed to jointly study the dangerous pathogens that could cause future pandemics.
\n \n\n \n \n21 March 2023
\n \n \n \nAcademic representatives from Benem\u00e9rita Universidad Aut\u00f3noma de Puebla (BUAP), one of the leading universities in Mexico, paid a visit to NDM\u2019s Jenner Institute.
\n \n\n \n \n20 March 2023
\n \n \n \nThe Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.
\n \n\n \n \n17 March 2023
\n \n \n \nThe Dr Stanley Ho Medical Development Foundation will continue its funding support for The Centre for Personalised Medicine (CPM) for further seven years.
\n \n\n \n \n10 March 2023
\n \n \n \nRare diseases are a global health challenge. To address this, organisations around the world, including the Nuffield Department of Medicine (NDM), are working together to find solutions for patients.
\n \n\n \n \n21 February 2023
\n \n \n \nThe Coronavirus Vaccines Research and Development Roadmap is a comprehensive plan to galvanize a global effort to protect the world from this large and dangerous family of viruses.
\n \n\n \n \n15 February 2023
\n \n \n \nThe Lithuanian Ambassador to the United Kingdom, His Excellency Mr Eitvydas Bajar\u016bnas, paid a visit to Professor Skirmantas Kriau\u010dionis of the Ludwig Institute for Cancer Research at the Nuffield Department of Medicine.
\n \n\n \n \n7 February 2023
\n \n \n \nDART (Dengue Advanced Readiness Tools), is a new project supported by Wellcome to use climate data to better predict and prepare for infectious diseases outbreaks.
\n \n\n \n \n1 February 2023
\n \n \n \nThe Mahidol Oxford Tropical Medicine Research Unit (MORU) has begun a Phase II trial to demonstrate that R21/matrix M is well-tolerated and immunogenic when administered with the antimalarial drug combination.
\n \n\n \n \n25 January 2023
\n \n \n \nDPhil student at the Jenner Institute, Romain Guyon is among the researchers who received the 2022 Michelson Prizes: Next Generation Grants, announced by Michelson Medical Research Foundation and Human Immunome Project.
\n \n\n \n \n20 January 2023
\n \n \n \nSince the start of the pandemic, the CAMS-Oxford Institute (COI) has carried out 11 projects to better understand COVID-19, resulting in 21 published research articles.
\n \n\n \n \n12 January 2023
\n \n \n \nA new Memorandum of Understanding (MoU) to facilitate collaboration in the field of pandemic preparedness and to promote further cooperation between the University of Oxford and Diamond Light Source, the UK\u2019s national synchrotron has been agreed upon.
\n \n\n \n \n10 January 2023
\n \n \n \nProfessor Dame Sarah Gilbert, the Sa\u00efd Chair of Vaccinology in the Nuffield Department of Medicine has been selected to receive King Faisal Prize for Medicine for 2023, along with Professor Dan Barouch of Harvard Medical School.
\n \n\n \n \n5 January 2023
\n \n \n \nWe are delighted to announce that three researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
\n \n\n \n \n16 December 2022
\n \n \n \nMore than 40,000 doses of Oxford\u2019s Ebola vaccine have been manufactured by Serum Institute of India (SII) in just 60 days and doses shipped to Uganda.
\n \n\n \n \n8 December 2022
\n \n \n \nThe inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.
\n \n\n \n \n5 December 2022
\n \n \n \nContinual monitoring of genetic changes in parasite populations is a powerful tool for analysing malaria outbreaks and identifying emerging multidrug-resistant malaria strains, say researchers from NDM\u2019s Mahidol-Oxford Tropical Medicine Research Unit (MORU).
\n \n\n \n \n2 December 2022
\n \n \n \nThe study from the Worldwide Antimalarial Resistance Network (WWARN) provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.
\n \n\n \n \n